• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

混合磷脂囊泡催化抑制并逆转淀粉样纤维形成。

Mixed Phospholipid Vesicles Catalytically Inhibit and Reverse Amyloid Fibril Formation.

机构信息

Department of Chemical and Biological Engineering, University of Colorado, Boulder, Colorado 80309, United States.

Department of Molecular, Cellular and Developmental Biology, University of Colorado, Boulder, Colorado 80309, United States.

出版信息

J Phys Chem Lett. 2020 Sep 3;11(17):7417-7422. doi: 10.1021/acs.jpclett.0c02074. Epub 2020 Aug 25.

DOI:10.1021/acs.jpclett.0c02074
PMID:32803986
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC10164471/
Abstract

While many approaches to reduce fibrillation of amyloid-β (Aβ) have been aimed at slowing fibril formation, the degradation of fibrils remains challenging. We provide insight into fibril degradation as well as the inhibition of fiber formation by lipid vesicles composed of 1,2-dioleoyl--glycero-3-phosphocholine and 1,2-dioleoyl--glycero-3-phospho-(1'-rac-glycerol). In the presence of vesicles with the optimal lipid composition, fibril formation was inhibited up to 76%. Additionally, by tuning the lipid composition, mature fibril content decreased up to 74% and the β-sheet content of Aβ was significantly reduced. The reduction in fibril and β-sheet content was consistent with a decrease in fibril diameter and could be attributed to the chaperone-like activity of the mixed vesicles. While demonstrating this remarkable activity, our findings present new evidence that lipid composition has a significant effect on the strength of the interaction between lipid bilayers and Aβ peptides/fibrils. This understanding has intriguing therapeutic implications in treating protein misfolding diseases.

摘要

虽然许多减少淀粉样蛋白-β(Aβ)纤维形成的方法都旨在减缓纤维的形成,但纤维的降解仍然具有挑战性。我们深入研究了纤维的降解以及由 1,2-二油酰基-sn-甘油-3-磷酸胆碱和 1,2-二油酰基-sn-甘油-3-磷酸-(1'-rac-甘油)组成的脂质体对纤维形成的抑制作用。在具有最佳脂质组成的囊泡存在的情况下,纤维形成被抑制了高达 76%。此外,通过调整脂质组成,成熟纤维的含量降低了高达 74%,并且 Aβ 的β-折叠含量显著降低。纤维和β-折叠含量的降低与纤维直径的减小一致,这归因于混合囊泡的伴侣样活性。虽然证明了这种显著的活性,但我们的研究结果提供了新的证据,表明脂质组成对脂双层与 Aβ 肽/纤维之间相互作用的强度有显著影响。这一认识在治疗蛋白质错误折叠疾病方面具有有趣的治疗意义。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/34ea/10164471/0f727327c9bc/nihms-1893219-f0005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/34ea/10164471/a0779dd1301c/nihms-1893219-f0002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/34ea/10164471/9b4c0ca90128/nihms-1893219-f0003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/34ea/10164471/06bea271ae9a/nihms-1893219-f0004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/34ea/10164471/0f727327c9bc/nihms-1893219-f0005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/34ea/10164471/a0779dd1301c/nihms-1893219-f0002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/34ea/10164471/9b4c0ca90128/nihms-1893219-f0003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/34ea/10164471/06bea271ae9a/nihms-1893219-f0004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/34ea/10164471/0f727327c9bc/nihms-1893219-f0005.jpg

相似文献

1
Mixed Phospholipid Vesicles Catalytically Inhibit and Reverse Amyloid Fibril Formation.混合磷脂囊泡催化抑制并逆转淀粉样纤维形成。
J Phys Chem Lett. 2020 Sep 3;11(17):7417-7422. doi: 10.1021/acs.jpclett.0c02074. Epub 2020 Aug 25.
2
Evaluation of membrane models and their composition for islet amyloid polypeptide-membrane aggregation.用于胰岛淀粉样多肽-膜聚集的膜模型及其组成的评估。
Biochim Biophys Acta. 2013 Sep;1828(9):2091-8. doi: 10.1016/j.bbamem.2013.05.014. Epub 2013 May 23.
3
Lipid membrane templates the ordering and induces the fibrillogenesis of Alzheimer's disease amyloid-beta peptide.脂质膜为阿尔茨海默病β淀粉样肽的有序排列提供模板并诱导其纤维形成。
Proteins. 2008 Jul;72(1):1-24. doi: 10.1002/prot.21887.
4
Inhibition of lysozyme amyloidogenesis by phospholipids. Focus on long-chain dimyristoylphosphocholine.磷脂对溶菌酶淀粉样纤维形成的抑制作用。以长链二肉豆蔻酰磷脂酰胆碱为重点。
Biochim Biophys Acta Gen Subj. 2017 Nov;1861(11 Pt A):2934-2943. doi: 10.1016/j.bbagen.2017.08.023. Epub 2017 Sep 1.
5
Lipid membranes catalyse the fibril formation of the amyloid-β (1-42) peptide through lipid-fibril interactions that reinforce secondary pathways.脂膜通过脂质-纤维相互作用促进二级途径来催化淀粉样β(1-42)肽的纤维形成。
Biochim Biophys Acta Biomembr. 2017 Oct;1859(10):1921-1929. doi: 10.1016/j.bbamem.2017.05.012. Epub 2017 May 28.
6
Unraveling amyloid formation paths of Parkinson's disease protein α-synuclein triggered by anionic vesicles.解析帕金森病蛋白α-突触核蛋白在阴离子囊泡触发下的淀粉样形成途径。
Q Rev Biophys. 2017 Jan;50:e3. doi: 10.1017/S0033583517000026.
7
Induction, inhibition, and incorporation: Different roles for anionic and zwitterionic lysolipids in the fibrillation of the functional amyloid FapC.诱导、抑制和掺入:阴离子和两性离子溶血磷脂在功能型淀粉样蛋白 FapC 纤维形成中的不同作用。
J Biol Chem. 2022 Feb;298(2):101569. doi: 10.1016/j.jbc.2022.101569. Epub 2022 Jan 7.
8
Amyloid-β aggregation on model lipid membranes: an atomic force microscopy study.淀粉样β蛋白在模型类脂膜上的聚集:原子力显微镜研究。
J Alzheimers Dis. 2011;26(3):485-94. doi: 10.3233/JAD-2011-102112.
9
Both beta sheet breaker and alpha helix forming pentapeptide inhibits protein fibrillation: Implication for the treatment of amyloid disorders.β 折叠破坏肽和 α 螺旋形成五肽均可抑制蛋白纤维形成:用于治疗淀粉样变性疾病的启示。
Int J Biol Macromol. 2020 Jan 15;143:102-111. doi: 10.1016/j.ijbiomac.2019.11.222. Epub 2019 Dec 4.
10
Tuning the surface charge of phospholipid bilayers inhibits insulin fibrilization.调整磷脂双层的表面电荷可抑制胰岛素纤维化。
Colloids Surf B Biointerfaces. 2022 Dec;220:112904. doi: 10.1016/j.colsurfb.2022.112904. Epub 2022 Oct 13.

引用本文的文献

1
A Novel Tetrahydroacridine Derivative with Potent Acetylcholinesterase Inhibitory Properties and Dissociative Capability against Aβ42 Fibrils Confirmed by In Vitro Studies.一种新型四氢吖啶衍生物具有强大的乙酰胆碱酯酶抑制特性和体外研究证实的对 Aβ42 纤维的解离能力。
Int J Mol Sci. 2024 Sep 19;25(18):10072. doi: 10.3390/ijms251810072.
2
Tuning the surface charge of phospholipid bilayers inhibits insulin fibrilization.调整磷脂双层的表面电荷可抑制胰岛素纤维化。
Colloids Surf B Biointerfaces. 2022 Dec;220:112904. doi: 10.1016/j.colsurfb.2022.112904. Epub 2022 Oct 13.
3
Mitochondrial membranes modify mutant huntingtin aggregation.

本文引用的文献

1
Structure-based inhibitors of amyloid beta core suggest a common interface with tau.基于结构的淀粉样β核心抑制剂提示与 tau 具有共同的界面。
Elife. 2019 Oct 15;8:e46924. doi: 10.7554/eLife.46924.
2
α-Sheet secondary structure in amyloid β-peptide drives aggregation and toxicity in Alzheimer's disease.淀粉样 β 肽中的 α-折叠二级结构驱动阿尔茨海默病中的聚集和毒性。
Proc Natl Acad Sci U S A. 2019 Apr 30;116(18):8895-8900. doi: 10.1073/pnas.1820585116. Epub 2019 Apr 19.
3
Stabilization of Immobilized Enzymes via the Chaperone-Like Activity of Mixed Lipid Bilayers.
线粒体膜改变突变型亨廷顿蛋白的聚集。
Biochim Biophys Acta Biomembr. 2021 Oct 1;1863(10):183663. doi: 10.1016/j.bbamem.2021.183663. Epub 2021 Jun 2.
4
Lipid membranes induce structural conversion from amyloid oligomers to fibrils.脂膜诱导淀粉样寡聚体到纤维的结构转换。
Biochem Biophys Res Commun. 2021 Jun 11;557:122-126. doi: 10.1016/j.bbrc.2021.03.174. Epub 2021 Apr 14.
固定化酶通过混合脂质双层的伴侣样活性实现稳定。
ACS Appl Mater Interfaces. 2018 Jun 13;10(23):19504-19513. doi: 10.1021/acsami.8b05523. Epub 2018 May 29.
4
Model membrane size-dependent amyloidogenesis of Alzheimer's amyloid-β peptides.阿尔茨海默病淀粉样β肽的模型膜大小依赖性淀粉样蛋白生成
Phys Chem Chem Phys. 2017 Jun 21;19(24):16257-16266. doi: 10.1039/c6cp07774a.
5
Lipid membranes catalyse the fibril formation of the amyloid-β (1-42) peptide through lipid-fibril interactions that reinforce secondary pathways.脂膜通过脂质-纤维相互作用促进二级途径来催化淀粉样β(1-42)肽的纤维形成。
Biochim Biophys Acta Biomembr. 2017 Oct;1859(10):1921-1929. doi: 10.1016/j.bbamem.2017.05.012. Epub 2017 May 28.
6
Protein Misfolding Diseases.蛋白质错误折叠疾病。
Annu Rev Biochem. 2017 Jun 20;86:21-26. doi: 10.1146/annurev-biochem-061516-044518. Epub 2017 Apr 24.
7
Liposomal Formulations in Clinical Use: An Updated Review.临床应用中的脂质体制剂:最新综述。
Pharmaceutics. 2017 Mar 27;9(2):12. doi: 10.3390/pharmaceutics9020012.
8
Systematic development of small molecules to inhibit specific microscopic steps of Aβ42 aggregation in Alzheimer's disease.系统性开发小分子以抑制阿尔茨海默病中Aβ42聚集的特定微观步骤。
Proc Natl Acad Sci U S A. 2017 Jan 10;114(2):E200-E208. doi: 10.1073/pnas.1615613114. Epub 2016 Dec 23.
9
Therapeutic strategies for Alzheimer's disease in clinical trials.临床试验中阿尔茨海默病的治疗策略。
Pharmacol Rep. 2016 Feb;68(1):127-38. doi: 10.1016/j.pharep.2015.07.006. Epub 2015 Aug 5.
10
Validation and Characterization of a Novel Peptide That Binds Monomeric and Aggregated β-Amyloid and Inhibits the Formation of Neurotoxic Oligomers.一种新型肽的验证与特性研究,该肽可结合单体和聚集态的β-淀粉样蛋白并抑制神经毒性寡聚体的形成
J Biol Chem. 2016 Jan 8;291(2):547-59. doi: 10.1074/jbc.M115.679993. Epub 2015 Nov 4.